Trade this ETF at your broker
Index | S&P 500 Capped 35/20 Health Care |
Investment focus | Equity, United States, Health Care |
Fund size | EUR 2,044 m |
Total expense ratio | 0.15% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 11.89% |
Inception/ Listing Date | 20 November 2015 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | iShares |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | State Street Fund Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Deloitte |
Fiscal Year End | 30 November |
Swiss representative | BlackRock Asset Management Schweiz AG |
Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
Tax data | Bundesanzeiger | |
Germany | 30% tax rebate | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
Securities lending | Yes |
Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
Eli Lilly & Co | 11.32% |
UnitedHealth Group | 8.35% |
Johnson & Johnson | 6.95% |
Merck & Co | 6.10% |
AbbVie | 5.87% |
Thermo Fisher Scientific | 4.10% |
Abbott Laboratories | 3.60% |
Danaher | 3.00% |
Pfizer | 2.86% |
Amgen | 2.78% |
United States | 96.28% |
Ireland | 2.52% |
Other | 1.20% |
Health Care | 98.80% |
Other | 1.20% |
Broker | Rating | Savings plan offer | Account fee | More information |
---|---|---|---|---|
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info |
YTD | +8.42% |
1 month | +2.25% |
3 months | +0.00% |
6 months | +13.62% |
1 year | +11.55% |
3 years | +35.81% |
5 years | +81.39% |
Since inception (MAX) | +126.74% |
2023 | -1.84% |
2022 | +3.70% |
2021 | +36.17% |
2020 | +3.43% |
Volatility 1 year | 11.89% |
Volatility 3 years | 15.67% |
Volatility 5 years | 19.39% |
Return per risk 1 year | 0.97 |
Return per risk 3 years | 0.69 |
Return per risk 5 years | 0.65 |
Maximum drawdown 1 year | -6.20% |
Maximum drawdown 3 years | -14.24% |
Maximum drawdown 5 years | -27.77% |
Maximum drawdown since inception | -27.77% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
London Stock Exchange | GBX | IHCU | - - | - - | - |
gettex | EUR | QDVG | - - | - - | - |
Stuttgart Stock Exchange | EUR | QDVG | - - | - - | - |
Bolsa Mexicana de Valores | MXN | - | IUHCN MM | IUHCN.MX | |
London Stock Exchange | USD | IUHC | IUHC LN INAVIHCU | IHCU.L 3094INAV.DE | |
London Stock Exchange | GBP | - | IHCU LN INAVIHCG | IUHC.L 3092INAV.DE | |
SIX Swiss Exchange | USD | IUHC | IUHC SE INAVIHCU | IUHC.S 3094INAV.DE | |
XETRA | EUR | QDVG | QDVG GY INAVIHCE | QDVG.DE 309ZINAV.DE |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
Xtrackers MSCI USA Health Care UCITS ETF 1D | 741 | 0.12% p.a. | Distributing | Full replication |
iShares Nasdaq US Biotechnology UCITS ETF | 437 | 0.35% p.a. | Accumulating | Sampling |
SPDR S&P US Health Care Select Sector UCITS ETF | 357 | 0.15% p.a. | Accumulating | Full replication |
Invesco Nasdaq Biotech UCITS ETF | 312 | 0.40% p.a. | Accumulating | Swap-based |
Invesco US Health Care Sector UCITS ETF | 292 | 0.14% p.a. | Accumulating | Swap-based |